
Regent Pacific Sees Strong Growth Outlook for AI-Driven Longevity Technologies Amid China’s 15th Five-Year Plan
In a recent conversation with AsiaBizToday, Jamie Gibson, Executive Director and CEO of Regent Pacific, outlined why the company believes its wholly owned subsidiary Deep Longevity—a specialist in AI-powered aging clock technologies—is well placed to benefit from demographic shifts, rising demand for preventive healthcare, and cross-border data reforms.






















